Get started
Author

Javier Bustamante

Observed names: F. Javier Bustamante, F.J. Bustamante, Francisco J Bustamante, Francisco Javier Bustamante, J Bustamante, J. Bustamante
Institution: Hospital de Cruces
Observed institutions: University of the Basque Country, BioCruces Health research Institute, Marqués de Valdecilla University Hospital, Hospital Clínic de Barcelona, Osakidetza, Hospital Universitario Doctor Peset, Hospital de Cruces, Hospital Universitario Río Hortega, Universitat de Barcelona
ORCID: 0000-0002-5280-3038
Observed ORCID: 0000-0002-5280-3038
OpenAlex ID: A5103281246
Natural History of Untreated Nonsurgical Hepatocellular Carcinoma: Rationale for the Design and Evaluation of Therapeutic Trials
1999 · Josep M. Llovet, Javier Bustamante, et al. · Hepatology · 1,199
Prognostic significance of hepatic encephalopathy in patients with cirrhosis
1999 · Javier Bustamante, Antoni Rimola, et al. · Journal of Hepatology · 571
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma
2023 · Ainhoa Lapitz, Mikel Azkargorta, et al. · Journal of Hepatology · 197
PDF
Efficacy and Safety of Sorafenib in Combination With Mammalian Target of Rapamycin Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation
2011 · Carlos Gomez-Martin, Javier Bustamante, et al. · Liver Transplantation · 163
PDF
Diabetes mellitus after liver transplantation: prevalence and predictive factors
1996 · Miquel Navasa, Javier Bustamante, et al. · Journal of Hepatology · 150
Murine double minute 2 regulates Hu antigen R stability in human liver and colon cancer through NEDDylation
2011 · Nieves Embade, David Fernández-Ramos, et al. · Hepatology · 135
Management of Hepatocellular Carcinoma Recurrence After Liver Transplantation
2010 · A. Valdivieso, J. Bustamante, et al. · Transplantation Proceedings · 107
Favorable Outcomes After Liver Transplantation With Normothermic Regional Perfusion From Donors After Circulatory Death: A Single-center Experience
2018 · Patricia Ruiz, Mikel Gastaca, et al. · Transplantation · 72
Activation of LKB1-Akt Pathway Independent of Phosphoinositide 3-Kinase Plays a Critical Role in the Proliferation of Hepatocellular Carcinoma From Nonalcoholic Steatohepatitis
2010 · Nuria Martínez-López, Marta Varela-Rey, et al. · Hepatology · 70
Diagnóstico y tratamiento del carcinoma hepatocelular. Actualización del documento de consenso de la AEEH, AEC, SEOM, SERAM, SERVEI y SETH
2021 · María Reig, Alejandro Forner, et al. · Medicina Clínica · 63
Similar Results in Liver Transplantation From Controlled Donation After Circulatory Death Donors With Normothermic Regional Perfusion and Donation After Brain Death Donors: A Case‐Matched Single‐Center Study
2021 · Patricia Ruiz, Andres Valdivieso, et al. · Liver Transplantation · 62
Tratamiento del carcinoma hepatocelular en España. Análisis de 705 casos en 62 centros
2009 · María Varela, María Reig, et al. · Medicina Clínica · 54
Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH
2021 · María Reig, Alejandro Forner, et al. · Medicina Clínica (English Edition) · 42
Neutrophil-to-lymphocyte ratio predicts survival in European patients with hepatocellular carcinoma administered sorafenib
2017 · Alberto Lué, Maria Trinidad Serrano, et al. · Oncotarget · 42
PDF
Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain
2015 · Itxarone Bilbao, Magdalena Salcedo, et al. · Liver Transplantation · 40
PDF
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
2021 · Aránzazu Caballero-Marcos, Magdalena Salcedo, et al. · American Journal of Transplantation · 38
PDF
Liver transplantation for hepatocellular carcinoma in cirrhotic patients
2003 · J González-Uriarte, A Valdivieso, et al. · Transplantation Proceedings · 27
Biliary Complications in Orthotopic Liver Transplantation Using Choledochocholedochostomy with a T-tube
2012 · M. Gastaca, A. Matarranz, et al. · Transplantation Proceedings · 22
Prophylactic Therapy With Valgancyclovir in High-Risk (Cytomegalovirus D+/R−) Liver Transplant Recipients: A Single-Center Experience
2009 · M. Montejo, E. Montejo, et al. · Transplantation Proceedings · 20
Differential expression of viral PAMP receptors mRNA in peripheral blood of patients with chronic hepatitis C infection
2007 · Rafael Atencia, Francisco J Bustamante, et al. · BMC Infectious Diseases · 20
PDF
Favorable longterm outcomes of liver transplant recipients treated de novo with once‐daily tacrolimus: Results of a single‐center cohort
2016 · Mikel Gastaca, Andrés Valdivieso, et al. · Liver Transplantation · 18
Survival and Hepatitis C Virus Recurrence After Liver Transplantation in HIV- and Hepatitis C Virus–Coinfected Patients: Experience in a Single Center
2009 · M. Testillano, J.R. Fernandez, et al. · Transplantation Proceedings · 13
Decreased Long‐Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019
2021 · Aránzazu Caballero‐Marcos, María Jesús Citores, et al. · Liver Transplantation · 11
Evolving epidemiology of HCC in Spain
2025 · Margarita Sala, Sonia Pascual, et al. · JHEP Reports · 10
PDF
Decisiones terapéuticas en el tratamiento del carcinoma hepatocelular y patrones de uso de sorafenib. Resultados del estudio internacional observacional GIDEON en España
2015 · Juan Turnes, Roberto Díaz, et al. · Gastroenterología y Hepatología · 8
Works count: 57
Citation count: 3,221
H-index: 20
I10-index: 24
Year
Topic
Type